Completed
A Study to Assess the Pharmacokinetics, Safety and Tolerability of CT327 in Healthy Male Volunteers
NCT01243502
- Conditions
- Safety
- Locations
-
Not specified
Clinical trial condition
Safety
Explore clinical trials studying Safety. Study availability and eligibility vary by location and protocol.
159 public trials
24 recruiting studies
Safety trial results
NCT00696865
- Conditions
- Healthy, Safety
- Locations
-
- Research Site Kanagawa, Japan
NCT00256386
- Conditions
- Safety
- Locations
-
- Kaiser Permanente Center for Health Research Portland, Oregon, United States
Active, Not Recruiting
Phase 3 Infant Safety & Immunogenicity Trial of MVA-BN® in DRC
NCT06844487
- Conditions
- Animal Diseases, Children, DNA Virus Infections, +12 more
- Locations
-
- Boende Hôpital Général de Référence, Boende Boende, La Tshuapa, Democratic Republic of the Congo
Active, Not Recruiting
Safety and Efficacy of Distal Radial Access (SAFE-BOX)
NCT05776550
- Conditions
- Efficacy, Safety
- Locations
-
- Yongcheol Kim Yongin, Gyeonggi-do, South Korea
Active, Not Recruiting
Korea Comirnaty Post-marketing Surveillance
NCT05032976
- Conditions
- Adverse Effects, COVID-19, Coronaviridae Infections, +13 more
- Locations
-
- Pfizer Seoul, South Korea
Active, Not Recruiting
Phase 3 Maternal Safety & Immunogenicity Trial of MVA-BN® in DRC
NCT06844500
- Conditions
- Animal Diseases, DNA Virus Infections, Immunogenicity, +14 more
- Locations
-
- Boende Hôpital Général de Référence Boende, Province de La Tshuapa, Democratic Republic of the Congo
Active, Not Recruiting
Prospective G7 Dual Mobility Total Hip PMCF
NCT03308929
- Conditions
- Clinical Outcomes, Functional Outcomes, Radiological Outcomes, +2 more
- Locations
-
- Jersey City Medical Center Jersey City, New Jersey, United States
- New Mexico Orthopaedics Albuquerque, New Mexico, United States
- University of North Carolina Chapel Hill, North Carolina, United States
- Oregon Health and Science University Portland, Oregon, United States
Active, Not Recruiting
FCN-338 in Combination With Azacitidine or Chemotherapy in Myeloid Neoplasms
NCT06858618
- Conditions
- Antitumor Activity, Hematologic Diseases, Hemic and Lymphatic Diseases, +7 more
- Locations
-
- Union hospital tongjimedical college huzhong university of science and technology Wuhan, China